Pulse 2.0 interviewed MTM alumnus Sungwon Lim, founder of ImpriMed, a company that provides personalized medicine for pets with blood cancer diseases.
alumni
Alumnus Di Carlo will lead new UCLA Chan Zuckerberg Initiative cell research project
The Chan Zuckerberg Initiative has allocated a $4 million grant to support collaborative research by UCLA, USC and CalTech that will examine cellular behaviors, many of which play a key role in developing immunity to pathogens and disease. Dino Di Carlo, UCLA professor of bioengineering and UC Berkeley BS and PhD alumnus, will lead the team.
Tsuchida and Vasic in 30 Under 30
PhD alumni Connor Tsuchida and Ivana Vasic have both been named to the annual Forbes 30 Under 30 list for their achievements in Healthcare! Tsuchida has founded Crispr delivery startup Azalea Therapeutics, and Vasic is developing therapies to support the next generation of in vitro fertilization as founder of Vitra Labs.
Two alumni innovations named to Time 2023 Best Inventions
Two PhD alumni have innovations named to the Time Magazine 200 Best Inventions of 2023 list. The Cala kIQ, developed by Cala Health, founded by alumna Kate Rosenbluth, is a wearable device that assists patients with Essential Tremor and Parkinson’s. Proven 40 OS is a fertilizer using naturally occurring microbes to reduce emissions and pollution while producing higher crop yields – developed by Pivot Bio, founded by alumnus Karsten Temme.
Aluna named Tech for Global Good Laureate
BioE startup Aluna, founded by alumna Charvi Shetty, has been named a 2023-24 Tech for Global Good Laureate, one of four venures recognized for using technology to significantly advance health equity and improve lives. Aluna makes hardware and software that helps people with breathing problems.
Wilbur Lam named to National Academy of Medicine
PhD alumnus Wilbur Lam, now Professor of Pediatrics and Biomedical Engineering, Emory University and Georgia Tech, has been named one of the 2023 new members of the National Academy of Medicine. Lam was recognized for “outstanding contributions in point-of-care, home-based, and/or smartphone-enabled diagnostics that are changing the management of pediatric and hematologic diseases as well as development of microsystems technologies as research-enabling platforms to investigate blood biophysics. He also leads national/NIH efforts to assess diagnostic tests (including those for COVID-19) for the entire country.”
Bolt Threads going public
Bolt Threads, a company co-founded by BioE PhD alumnus David Breslauer, plans to go public in a SPAC deal that values the one-time unicorn at $250 million. Bolt Threads uses synthetic biology and other techniques to sustainably produce engineered biomaterials, including synthetic spider silk and mushroom-based faux leather.
Vlassakis receives NIH New Innovator Award
PhD alumna Julea Vlassakis, now Assistant Professor of Bioengineering at Rice University, has been named a 2023 NIH Director’s New Innovator! These prestigious awards support early-career investigators with ambitious, unconventional project proposals demonstrating broad impact potential.
BioE alumna creating a greener future for bluejeans
PhD alumna Tammy Hsu is using synthetic biology to produce environmentally friendly dyes for industry through her company, Huue.